Insider transaction 📈 Stocks 🌍 United States ISIN US88076W1036

Teradata CEO Stephen McMillan Sells 10,000 Shares Under Trading Plan

CEO Stephen McMillan offloaded 10,000 Teradata shares via a pre-planned 10b5-1 arrangement, maintaining a substantial $22 million equity position in the enterprise data analytics firm.

🕐 1 min read

4 assets impacted (Stocks). Net bias: 0 Bullish, 0 Bearish, 4 Neutral. Strongest signal: TDC → 2/10 (70% confidence).

📊 Affected Assets (4)

TDC
Neutral 🤖 70%
📅 Short-term 🌍 US · Explicit

CEO sold 10,000 shares under a pre-existing Rule 10b5-1 plan, retaining a substantial stake, making the sale non-discretionary and not a bearish signal.

SPX
Neutral 🤖 35%
🗓️ Long-term 🌍 US ✨ Inferred

Referenced as a benchmark to highlight Motley Fool's stock advisor performance, not central to the article.

NFLX
Neutral 🤖 25%
🗓️ Long-term 🌍 US ✨ Inferred

Mentioned only as a historical example of a Motley Fool stock pick, with no direct relevance to the article's subject.

NVDA
Neutral 🤖 25%
🗓️ Long-term 🌍 US ✨ Inferred

Mentioned only as a historical example of a Motley Fool stock pick, with no direct relevance to the article's subject.

🎯 Key Takeaways

  • The sale of 10,000 shares was non-discretionary, executed under a Rule 10b5-1 plan established in May 2026.
  • McMillan retains a direct holding of 752,446 shares, representing approximately 0.80% of Teradata's total outstanding stock.
  • Teradata maintains a strong financial profile with a 26.94% net margin and $1.7 billion in trailing 12-month revenue.

📝 Executive Summary

Teradata Corporation CEO Stephen McMillan sold 10,000 shares of company stock on September 15, 2026, for approximately $300,200. The transaction was executed under a pre-established Rule 10b5-1 trading plan, indicating a non-discretionary move rather than a shift in sentiment. McMillan retains a significant direct stake of over 752,000 shares, valued at roughly $22.11 million.

❓ FAQ

Does the CEO's stock sale indicate a lack of confidence in Teradata?

No. The sale was executed under a Rule 10b5-1 trading plan, which is a pre-arranged schedule for selling shares to avoid concerns about insider trading. The CEO retains a significant $22 million stake in the company.